ALEXANDRIA, Va., April 7 -- United States Patent no. 12,594,341, issued on April 7.
"Multifunctional immunotherapeutic monoclonal antibody complexes and conjugates" was invented by Shimon Slavin (Tel Aviv, Israel).
According to the abstract* released by the U.S. Patent & Trademark Office: "Immunotherapeutic Monoclonal Antibody Complexes or Conjugates (IMAC) comprising readily accessible antibodies designed and approved for clinical use are provided using a one-step method that combines killing of existing cancer cells in parallel with induction of long-lasting anti-cancer vaccination. Methods for their use, alone or in combination with cancer killer cells including intentionally mismatched donor T cells, NK cells concomitantly with additi...